September 30, 2021
Thursday | 16:00 - 19:00 (GMT+3)

Session: COVID-19 and Rare Diseases (part I) 16:00 – 17:15 Moderators: Sandra Lejniece, MD, PhD (Riga Stradins University, Latvia) Sonata Šaulytė Trakymienė, MD, PhD (Vilnius University Hospital Santaros Klinikos, Lithuania)
16:00-16:03	Welcome Lina Kryžauskaitė, MD President of Lithuanian Hematology Society
16:03-16:05	Intro Sonata Šaulytė Trakymienė MD, PhD Vilnius University Hospital Santaros Klinikos, Lithuania
16:05–16:35	Vaccine-Induced Immune Thrombocytopenia and Thrombosis Sue Pavord, MD, Oxford University Hospitals, United Kingdom
16:35-16:50	SARS-CoV-2 Vaccine Induced Antibody Responses in Oncohematological Patients Kazimieras Maneikis, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
16:50-17:05	Role of Biobanking in Rare and Newly Emerged Disease Daniel Naumovas, Vilnius University Hospital Santaros Klinikos, Lithuania
17:05–17:15	Discussion
17:15–17:30	Break

Session: COVID-19 and Rare Diseases (part II) 17:30 – 19:05 Moderators: Jelena Rascon, MD, PhD (Vilnius University Hospital Santaros Klinikos, Lithuania) Andrius Degulys, MD (Vilnius University Hospital Santaros Klinikos, Lithuania)
17:30 - 17:35	Intro Jelena Rascon, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania
17:35-17:50	Bioinformatics in the Diagnosis of Inherited Predisposition to Hematological Disease Karolis Šablauskas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
17:50-18:20	Hemophagocytic lymphohistiocytosis: Primary or Secondary? Ashish R. Kumar, MD, PhD, Cincinnati Children’s Hospital Medical Center, USA
18:20-18:50	The Challenges of TMA: Posttransplant TTP / aHUS Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center, USA
18:50-19:05	Discussion

October 1, 2021
Friday | 15:40 - 20:00 (GMT+3)

Session: Acute Myeloid Leukemia 15:40 – 17:00 Moderators: Andrius Žučenka, MD (Vilnius University Hospital Santaros Klinikos, Lithuania)
15:40-15:45	Intro Andrius Žučenka, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
15:45-16:25	Changing Diagnosis and Treatment Paradigm in AML Farhad Ravandi, MD, The University of Texas MD Anderson Cancer Center, USA
16:25-16:45	Targeted Therapy in Relapsed/Refractory AML Andrius Žučenka, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
16:45-17:00	Discussion
17:00-17:15	Break

Session: The Challenge of Multiresistant Pathogens 17:15 – 18:20 Moderators: Laimonas Griškevičius, MD, PhD (Vilnius University Hospital Santaros Klinikos, Lithuania)
17:15-17:20	Intro Laimonas Griškevičius, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania
17:20–17:50	Challenges of Multiresistant Infections after Intesive Therapy Matteo Bassetti, MD, PhD, Policlinico San Martino University Hospital, Genoa, Italy
17:50-18:05	Genetic Evolution of SARS-CoV-2 Virus in Hematology Patients with Chronic Active COVID-19 Dovilė Juozapaitė, Vilnius University Hospital Santaros Klinikos, Lithuania
18:05-18:20	Discussion

18:30–20:00

Virtual Poster Exhibition

October 2, 2021
Saturday | 10:00 – 16:10 (GMT+3)

Session: Multiple Myeloma and Lymphoproliferative Disorders 10:00 – 13:00 Moderators: Valdas Pečeliūnas, MD, PhD (Vilnius University Hospital Santaros Klinikos, Lithuania) Mari Punab, MD (Tartu Ülikooli Kliinikum, Estonia)
10:00–10:05	Intro Valdas Pečeliūnas, MD, PhD, Vilnius University Hospital Santaros klinikos, Lithuania
10:05–10:35	Best Affordable Treatment for Multiple Myeloma Maria Victoria Mateos Manteca, MD, PhD, Department of Hematology, Hospital Clinico Universitario, Spain
10:35-10:50	Autologous HSCT for Multiple Myeloma with Renal Impairment Rolandas Gerbutavičius, MD, PhD, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Lithuania
10:50-11:05	Estonian myeloma audit (treatment and outcomes over 5 years) Dr. Mari Punab, Tartu Ülikooli Kliinikum, Estonia
11:05-11:10	Discussion
11:10-11:40	Relapsed/Refractory Diffuse Large B Cell Lymphoma: Current Treatment Options Andrew Davies, MD, PhD, University of Southampton, United Kingdom
11:40-12:00	AITL: It's face is not the issue Lukas Kevličius, MD, Ugnius Mickys, MD, Vilnius University Hospital Santaros klinikos, Lithuania
12:00-12:15	Discussion
12:15-13:00	Break

Session: Hematopoietic Stem Cell Transplantation. Cell Therapies. 13:00 – 16:30 Moderators: Artūras Slobinas, MD (Vilnius University Hospital Santaros Klinikos, Lithuania) Ain Kaare, MD (Tartu University Hospital Foundation, Estonia)
13:00–13:05	Intro Artūras Slobinas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
13:05–13:20	20 Years of Allogeneic HSCT Experience in Lithuania Rita Čekauskienė, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
13:20–13:35	20 Years of Autologous HSCT Experience in Lithuania Valdas Pečeliūnas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
13:35–13:50	Allogeneic and Autologous HSCT Experience in Estonia Ain Kaare, MD, Tartu University Hospital Foundation, Estonia
13:50-14:05	Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma Skirmantė Černauskienė, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
14:05-14:20	Role of Non-Myeloablative Conditioning in SAA Treatment Domas Vaitiekus, MD, PhD, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Lithuania
14:20-14:35	Discussion
14:35-14:50	Break

Session: Hematopoietic Stem Cell Transplantation. Cell Therapies.

13:00 – 16:30

Moderators:
Artūras Slobinas, MD (Vilnius University Hospital Santaros Klinikos, Lithuania)
Ain Kaare, MD (Tartu University Hospital Foundation, Estonia)

13:00–13:05

Intro

Artūras Slobinas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania

13:05–13:20

20 Years of Allogeneic HSCT Experience in Lithuania

Rita Čekauskienė, MD, Vilnius University Hospital Santaros Klinikos, Lithuania

13:20–13:35

20 Years of Autologous HSCT Experience in Lithuania

Valdas Pečeliūnas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania

13:35–13:50

Allogeneic and Autologous HSCT Experience in Estonia

Ain Kaare, MD, Tartu University Hospital Foundation, Estonia

13:50-14:05

Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma
Skirmantė Černauskienė, MD, Vilnius University Hospital Santaros Klinikos, Lithuania

14:05-14:20

Role of Non-Myeloablative Conditioning in SAA Treatment

Domas Vaitiekus, MD, PhD, Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Lithuania

14:20-14:35

Discussion

14:35-14:50

Break

Session: Hematopoietic Stem Cell Transplantation. Cell Therapies (part II) 14:50 – 16:30 Moderators: Adomas Bukauskas, MD (Vilnius University Hospital Santaros Klinikos, Lithuania) Artūras Slobinas, MD (Vilnius University Hospital Santaros Klinikos, Lithuania)
14:50 -14:55	Intro Adomas Bukauskas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
14:55-15:10	HSCT for Multiple Sclerosis: A Neurologist’s Perspective Nataša Giedraitienė, MD, PhD, Valdas Pečeliūnas, MD, PhD, Vilnius University Hospital Santaros Klinikos, Lithuania
15:10-15:25	Mesenchymal Cell Therapy Adomas Bukauskas, MD, Vilnius University Hospital Santaros Klinikos, Lithuania
15:25-15:40	Virus-specific T-cell Therapy Ieva Varanauskienė, Vilnius University Hospital Santaros Klinikos, Lithuania
15:40-16:10	Chimeric Antigen Receptor T-cell Toxicity Sattva S Neelapu, MD, The University of Texas MD Anderson Cancer Center, USA
16:10-16:15	Discussion
16:15-16:30	Congress Closing Remarks Lina Kryžauskaitė, Lithuania Sandra Lejniece, Latvia Mariken Ross, Estonia

Parallel Session: Pediatric and AYA Hematology and Oncology

2021-10-01 Friday 12:00 – 16:00
View agenda -> press HERE

Parallel Session: Nurse Session
2021-10-01 Friday 10:00 – 15:50
2021-10-02 Saturday 10:00 - 12:35

View agenda -> press HERE

Education Lecture
"Cardiovascular considerations in mulpitple myeloma. Cardiologist perspective" dr. Eglė Čiburienė (Vilnius University Hospital Santaros Klinikos, Clinic of Cardiac and Vascular diseases)

More information HERE